Hemogenyx Pharmaceuticals Plc (HEMO.L)
GBp 320.0
(-8.57%)
GBp 320.0
(-8.57%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -6.46 Million GBP | -261.75% |
| 2022 | 3.99 Million GBP | 247.91% |
| 2021 | -2.7 Million GBP | -25.69% |
| 2020 | -2.15 Million GBP | -27.69% |
| 2019 | -1.68 Million GBP | -4.27% |
| 2018 | -1.61 Million GBP | -96.75% |
| 2017 | -820.97 Thousand GBP | -57.91% |
| 2016 | -519.89 Thousand GBP | -206.08% |
| 2015 | -169.85 Thousand GBP | -2609.04% |
| 2014 | -6270.00 GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1345.57 GBP | 0.0% |
| 2024 Q1 | -1345.57 GBP | -100.48% |
| 2023 Q4 | -671.17 GBP | 40.33% |
| 2023 FY | -5.55 Million GBP | -239.05% |
| 2023 Q2 | -4.21 Million GBP | -199900.09% |
| 2023 Q3 | -1124.81 GBP | 99.97% |
| 2023 Q1 | -2108.11 GBP | 99.93% |
| 2022 Q2 | -1.14 Million GBP | -199899.3% |
| 2022 Q1 | -571.62 GBP | 99.96% |
| 2022 Q4 | -2.85 Million GBP | -199899.72% |
| 2022 FY | 3.99 Million GBP | 247.91% |
| 2022 Q3 | -1427.15 GBP | 99.88% |
| 2021 Q3 | -770.63 GBP | 99.93% |
| 2021 Q2 | -1.16 Million GBP | -199900.34% |
| 2021 Q1 | -580.75 GBP | 99.95% |
| 2021 Q4 | -1.54 Million GBP | -199900.52% |
| 2021 FY | -2.7 Million GBP | -25.69% |
| 2020 Q1 | -454.80 GBP | 99.95% |
| 2020 FY | -2.15 Million GBP | -27.69% |
| 2020 Q3 | -620.39 GBP | 99.93% |
| 2020 Q4 | -1.24 Million GBP | -199900.64% |
| 2020 Q2 | -909.6 Thousand GBP | -199900.0% |
| 2019 Q1 | -393.58 GBP | 16.42% |
| 2019 Q4 | -896.98 Thousand GBP | -199899.55% |
| 2019 FY | -1.68 Million GBP | -4.27% |
| 2019 Q2 | -787.15 Thousand GBP | -199899.49% |
| 2019 Q3 | -448.49 GBP | 99.94% |
| 2018 Q3 | -470.90 GBP | -27.23% |
| 2018 Q2 | -370.11 GBP | 0.0% |
| 2018 Q1 | -370.11 GBP | -16.25% |
| 2018 FY | -1.61 Million GBP | -96.75% |
| 2018 Q4 | -470.90 GBP | 0.0% |
| 2017 Q4 | -318.36 GBP | 0.0% |
| 2017 Q2 | -116.98 GBP | 0.0% |
| 2017 Q3 | -318.36 GBP | -172.16% |
| 2017 Q1 | -116.98 GBP | 0.0% |
| 2017 FY | -820.97 Thousand GBP | -57.91% |
| 2016 Q4 | - GBP | 0.0% |
| 2016 Q2 | - GBP | 0.0% |
| 2016 FY | -519.89 Thousand GBP | -206.08% |
| 2015 FY | -169.85 Thousand GBP | -2609.04% |
| 2014 FY | -6270.00 GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|